BerGenBio reports Q3 results

Nov. 15, 2022 9:18 AM ETBerGenBio ASA (BRRGF)By: Pranav Ghumatkar, SA News Editor
  • BerGenBio press release (OTCPK:BRRGF): Q3 Revenue amounted to NOK 0.0 million (NOK 0.0 million) for the third quarter 2022.
  • The operating loss for the third quarter came to NOK 62.4 million (NOK 71.4 million)
  • Cash and cash equivalents amounted to NOK 225.1 million (NOK 292.1 million at the end of the second quarter 2022).

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.